SEC Form 4 · accession 0001104659-17-060014
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Harrison Talbot
Director
Period of report
Sep 27, 2017
Accepted (ET)
Sep 29, 2017 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Sep 27, 2017 | M | 1,350 | — | A | 33,140 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F3 | — | Sep 27, 2017 | M | 1,350 | D | — | Sep 27, 2017 | Ordinary Shares | 1,350 | 0 | D |
Explanation of responses
- F1Dr. Talbot exercised his remaining stock options under the Company's Stock Option Plan 2007, which were set to expire on September 27, 2017. Dr. Talbot paid the exercise price in cash.
- F2The exercise price was .672 euros per share.
- F3These options were granted on various dates between 2009 and 2014 and are fully vested.